Efficacy Endpoints in Clinical Trials in Actinic Keratosis

INTRODUCTION: Actinic keratosis is regarded as a chronic disease of the skin and, although fluctuating, is chronically progressive. Approval of new products for the treatment of actinic keratosis requires the use of a standard methodology in clinical trials which emphasize complete clearance of all...

Descripción completa

Detalles Bibliográficos
Autores principales: Skov, Torsten, Stockfleth, Eggert, Szeimies, Rolf-Markus, Berman, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109027/
https://www.ncbi.nlm.nih.gov/pubmed/29916197
http://dx.doi.org/10.1007/s13555-018-0247-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109027/
https://www.ncbi.nlm.nih.gov/pubmed/29916197
http://dx.doi.org/10.1007/s13555-018-0247-0

Ejemplares similares